This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

National Funding Agency For Science And Technology In Portugal Selects Elsevier's Analytical Services To Support Evaluation Of R&D Units

Stocks in this article: ENL REN RUK

AMSTERDAM, June 10, 2014 /PRNewswire/ --

Data from Scopus ensures up-to-date presentation of researcher IDs in ORCID for five-year review of Portuguese R&D units 

Elsevier, a world-leading provider of scientific, technical and medical information products and services, has announced that it has been selected by the national funding agency for science and technology in Portugal, Fundação para a Ciência e a Tecnologia (FCT), to provide bibliometric analyses that will support its 2013/14 national review assessment of R&D units.

For the first time, FCT's review of R&D units in Portugal will include bibliometric analyses based on data from Elsevier's Scopus, the largest abstract and citation database of peer-reviewed literature. The analyses, which cover research production, impact and collaboration for the 2008-2012 period, are provided by Elsevier's Analytical Services, part of the Elsevier Research Intelligence portfolio of tools.

By selecting Scopus as the data source for the assessment, FCT was able to cover the broadest range of researchers based in Portugal and their publication and citation counts from 2008 to 2012. The 2013/14 assessment exercise includes 324 R&D Units and more than 15,000 researchers.

For the custom bibliometric analyses FCT opted for a process whereby all 15,000 researchers were able to update their unique identifier profiles in ORCID, an open, community-driven effort to create and maintain a registry of unique researcher identifiers and a transparent method of linking research activities and output to these identifiers. Thanks to the free Scopus-to-ORCID feedback wizard, created by Elsevier, researchers in Portugal were able to populate and update their ORCID IDs, ensuring that the bibliometric analyses provided to FCT for the assessment of the R&D units are based on current, accurate data.

Miguel Seabra, FCT President, said, "The bibliometric analyses conducted by Elsevier are an important component of the review process, providing very useful insights for the international review panels. Their involvement will thus contribute to the overall aim of this assessment exercise, which is to reinforce the role of research units as a fundamental pillar in building a modern and competitive scientific system."

Laure Haak, Executive Director of ORCID, said, "Researchers were able to use open tools in ORCID to search for their works, link to their ORCID record and at the same time make any needed adjustments to their Scopus author record. This large-scale implementation of ORCID demonstrated system resilience and scalability, and offers clear hope for researchers requesting to enter research information once, and re-use many times across research systems."

"We are delighted to support FCT with their research evaluation activities, not only by providing them with custom bibliometric analyses, but also in our collaborative approach of updating researcher records in ORCID - a step in the process which benefits all parties involved," said M'hamed el Aisati, Director of Content and Analytics at Elsevier. "We look forward to continue working with FCT, providing data and support for their future assessment initiatives."

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,959.44 +154.64 0.87%
S&P 500 2,078.54 +7.89 0.38%
NASDAQ 4,781.4240 +16.0440 0.34%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs